{"transactions":[{"id":4635392,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":20758,"kind":"person","name":"Fisher Danina","position":1,"cik":"0002144035","reported_name":"Fisher Danina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2026-10-03T00:30:28.000Z","date":"2026-09-29","kind":"purchase","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":200000,"derivative":{"exercise_price":0.06,"exercise_date":"2026-09-29","expiration_date":"2031-09-29","underlying":"Commmon Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-26-045526","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000149315226045526/ownership.xml","form_type":"4"}},{"id":4635391,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":20758,"kind":"person","name":"Fisher Danina","position":1,"cik":"0002144035","reported_name":"Fisher Danina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-03T00:30:28.000Z","date":"2026-09-29","kind":"purchase","planned":false,"acquired":true,"shares":200000,"price":0.05,"value":10000.0,"ownership":{"direct":true},"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001493152-26-045526","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000149315226045526/ownership.xml","form_type":"4"}},{"id":4616576,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":20831,"kind":"person","name":"LoPriore Vincent S","position":1,"cik":"0001633927","reported_name":"LoPriore Vincent S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Warrants","published_at":"2026-09-14T10:30:06.000Z","date":"2026-09-03","kind":"purchase","planned":false,"acquired":true,"shares":12500000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Gravitas Capital LP"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Warrant is only exercisable upon stockholder approval of an increase in the authorized shares of the Company's Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. LoPriore is the Managing Member of Gravitas Capital LP and in such capacity has the right to vote and dispose of the securities held by such entity."}],"balance_after":22500000,"derivative":{"exercise_price":0.06,"exercise_date":"2026-09-03","expiration_date":"2031-09-03","underlying":"Common Stock","underlying_shares":12500000},"source":{"system":"sec-edgar","filing":"0001493152-26-042470","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633927/000149315226042470/ownership.xml","form_type":"4"}},{"id":4614593,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":24126,"kind":"person","name":"Purcell Michael J.","position":1,"cik":"0001694934","reported_name":"Purcell Michael J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-09-10T20:15:15.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":299000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":299000,"derivative":{"exercise_price":0.08,"exercise_date":"2027-08-19","expiration_date":"2036-08-19","underlying":"Common Stock","underlying_shares":299000},"source":{"system":"sec-edgar","filing":"0001493152-26-042169","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694934/000149315226042169/ownership.xml","form_type":"4"}},{"id":678569,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":20773,"kind":"person","name":"Stetz Gary S.","position":1,"cik":"0001532793","reported_name":"Stetz Gary S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Stock Options","published_at":"2026-08-21T20:36:22.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":1345500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"336,375 options vest upon grant and the remaining amount vests in equal amounts monthly over 6 months from date of grant."}],"balance_after":1345500,"derivative":{"exercise_price":0.08,"exercise_date":"2026-08-19","expiration_date":"2036-08-19","underlying":"Common Stock","underlying_shares":1345500},"source":{"system":"sec-edgar","filing":"0001493152-26-039705","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1532793/000149315226039705/ownership.xml","form_type":"4"}},{"id":678756,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":20831,"kind":"person","name":"LoPriore Vincent S","position":1,"cik":"0001633927","reported_name":"LoPriore Vincent S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Options","published_at":"2026-08-21T20:34:34.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":1345500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"336,375 options vest upon grant and the remaining amount vests in equal amounts monthly over 6 months from date of grant."}],"balance_after":1345500,"derivative":{"exercise_price":0.08,"exercise_date":"2026-08-19","expiration_date":"2036-08-19","underlying":"Common Stock","underlying_shares":1345500},"source":{"system":"sec-edgar","filing":"0001493152-26-039702","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633927/000149315226039702/ownership.xml","form_type":"4"}},{"id":678522,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":20759,"kind":"person","name":"LoPriore Chase","position":1,"cik":"0002136903","reported_name":"LoPriore Chase","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Corp. Dev."}}],"security":"Stock Options","published_at":"2026-08-21T20:33:45.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":1345500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"336,375 options vest upon grant and the remaining amount vests in equal amounts monthly over 6 months from date of grant."}],"balance_after":1345500,"derivative":{"exercise_price":0.08,"exercise_date":"2026-08-19","expiration_date":"2036-08-19","underlying":"Common Stock","underlying_shares":1345500},"source":{"system":"sec-edgar","filing":"0001493152-26-039701","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000149315226039701/ownership.xml","form_type":"4"}},{"id":678521,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":20758,"kind":"person","name":"Fisher Danina","position":1,"cik":"0002144035","reported_name":"Fisher Danina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-08-21T20:31:42.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":299000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":299000,"derivative":{"exercise_price":0.08,"exercise_date":"2027-08-19","expiration_date":"2036-08-19","underlying":"Common Stock","underlying_shares":299000},"source":{"system":"sec-edgar","filing":"0001493152-26-039698","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000149315226039698/ownership.xml","form_type":"4"}},{"id":678520,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":20755,"kind":"person","name":"Liddy James Gordon","position":1,"cik":"0002082917","reported_name":"Liddy James Gordon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-08-21T20:30:07.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":299000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":299000,"derivative":{"exercise_price":0.08,"exercise_date":"2027-08-19","expiration_date":"2036-08-19","underlying":"Common Stock","underlying_shares":299000},"source":{"system":"sec-edgar","filing":"0001493152-26-039690","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000149315226039690/ownership.xml","form_type":"4"}},{"id":678519,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":20757,"kind":"person","name":"Appajosyula Sireesh","position":1,"cik":"0001901565","reported_name":"Appajosyula Sireesh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options","published_at":"2026-08-21T20:29:41.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":1345500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"336,375 options vest upon grant and the remaining amount vests in equal amounts monthly over 6 months from date of grant."}],"balance_after":1345500,"derivative":{"exercise_price":0.08,"exercise_date":"2026-08-19","expiration_date":"2036-08-19","underlying":"Common Stock","underlying_shares":1345500},"source":{"system":"sec-edgar","filing":"0001493152-26-039688","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000149315226039688/ownership.xml","form_type":"4"}},{"id":678518,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":20756,"kind":"person","name":"Stetz Gary S. II","position":1,"cik":"0002145064","reported_name":"Stetz Gary S. II","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-08-21T20:28:09.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":299000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":299000,"derivative":{"exercise_price":0.08,"exercise_date":"2027-08-19","expiration_date":"2036-08-19","underlying":"Common Stock","underlying_shares":299000},"source":{"system":"sec-edgar","filing":"0001493152-26-039685","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000149315226039685/ownership.xml","form_type":"4"}},{"id":688931,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":20756,"kind":"person","name":"Stetz Gary S. II","position":1,"cik":"0002145064","reported_name":"Stetz Gary S. II","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2026-08-13T01:43:01.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":500000,"derivative":{"exercise_price":0.06,"exercise_date":"2026-08-03","expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-26-037500","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000149315226037500/ownership.xml","form_type":"4"}},{"id":688930,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":20756,"kind":"person","name":"Stetz Gary S. II","position":1,"cik":"0002145064","reported_name":"Stetz Gary S. II","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-13T01:43:01.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":500000,"price":0.05,"value":25000.0,"ownership":{"direct":true},"balance_after":500000,"source":{"system":"sec-edgar","filing":"0001493152-26-037500","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000149315226037500/ownership.xml","form_type":"4"}},{"id":689003,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":20773,"kind":"person","name":"Stetz Gary S.","position":1,"cik":"0001532793","reported_name":"Stetz Gary S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Warrants","published_at":"2026-08-13T01:41:10.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2000000,"derivative":{"exercise_price":0.06,"exercise_date":"2026-08-03","expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001493152-26-037496","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1532793/000149315226037496/ownership.xml","form_type":"4"}},{"id":689002,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":20773,"kind":"person","name":"Stetz Gary S.","position":1,"cik":"0001532793","reported_name":"Stetz Gary S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2026-08-13T01:41:10.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":2000000,"price":0.05,"value":100000.0,"ownership":{"direct":true},"balance_after":3250000,"source":{"system":"sec-edgar","filing":"0001493152-26-037496","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1532793/000149315226037496/ownership.xml","form_type":"4"}},{"id":689276,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":24126,"kind":"person","name":"Purcell Michael J.","position":1,"cik":"0001694934","reported_name":"Purcell Michael J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2026-08-13T01:39:18.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2000000,"derivative":{"exercise_price":0.06,"exercise_date":"2026-08-03","expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001493152-26-037493","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1694934/000149315226037493/ownership.xml","form_type":"4"}},{"id":689275,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":24126,"kind":"person","name":"Purcell Michael J.","position":1,"cik":"0001694934","reported_name":"Purcell Michael J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-13T01:39:18.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":2000000,"price":0.05,"value":100000.0,"ownership":{"direct":true},"balance_after":3250000,"source":{"system":"sec-edgar","filing":"0001493152-26-037493","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694934/000149315226037493/ownership.xml","form_type":"4"}},{"id":688933,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":20757,"kind":"person","name":"Appajosyula Sireesh","position":1,"cik":"0001901565","reported_name":"Appajosyula Sireesh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Warrants","published_at":"2026-08-13T01:36:31.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2000000,"derivative":{"exercise_price":0.06,"exercise_date":"2026-08-03","expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001493152-26-037490","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000149315226037490/ownership.xml","form_type":"4"}},{"id":688932,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":20757,"kind":"person","name":"Appajosyula Sireesh","position":1,"cik":"0001901565","reported_name":"Appajosyula Sireesh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-08-13T01:36:31.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":2000000,"price":0.05,"value":100000.0,"ownership":{"direct":true},"balance_after":3250000,"source":{"system":"sec-edgar","filing":"0001493152-26-037490","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000149315226037490/ownership.xml","form_type":"4"}},{"id":689251,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":20831,"kind":"person","name":"LoPriore Vincent S","position":1,"cik":"0001633927","reported_name":"LoPriore Vincent S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Warrants","published_at":"2026-08-13T01:34:54.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Invictus Capital Advisors Pension Plan"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. LoPriore is the trustee and beneficiary of the Invictus Capital Advisors Pension Plan and in such capacity has the right to vote and dispose of the securities held by such entity."}],"balance_after":10000000,"derivative":{"exercise_price":0.06,"exercise_date":"2026-08-03","expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001493152-26-037489","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1633927/000149315226037489/ownership.xml","form_type":"4"}},{"id":689250,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":20831,"kind":"person","name":"LoPriore Vincent S","position":1,"cik":"0001633927","reported_name":"LoPriore Vincent S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Warrants","published_at":"2026-08-13T01:34:54.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":8000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Gravitas Capital LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. LoPriore is the Managing Member of Gravitas Capital LP and in such capacity has the right to vote and dispose of the securities held by such entity."}],"balance_after":8000000,"derivative":{"exercise_price":0.06,"exercise_date":"2026-08-03","expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":8000000},"source":{"system":"sec-edgar","filing":"0001493152-26-037489","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1633927/000149315226037489/ownership.xml","form_type":"4"}},{"id":689249,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":20831,"kind":"person","name":"LoPriore Vincent S","position":1,"cik":"0001633927","reported_name":"LoPriore Vincent S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-08-13T01:34:54.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":2000000,"price":0.05,"value":100000.0,"ownership":{"direct":false,"nature":"By Invictus Capital Advisors Pension Plan"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. LoPriore is the trustee and beneficiary of the Invictus Capital Advisors Pension Plan and in such capacity has the right to vote and dispose of the securities held by such entity."}],"balance_after":16250000,"source":{"system":"sec-edgar","filing":"0001493152-26-037489","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1633927/000149315226037489/ownership.xml","form_type":"4"}},{"id":689248,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":20831,"kind":"person","name":"LoPriore Vincent S","position":1,"cik":"0001633927","reported_name":"LoPriore Vincent S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-08-13T01:34:54.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":8000000,"price":0.05,"value":400000.0,"ownership":{"direct":false,"nature":"By Gravitas Capital LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. LoPriore is the Managing Member of Gravitas Capital LP and in such capacity has the right to vote and dispose of the securities held by such entity."}],"balance_after":14250000,"source":{"system":"sec-edgar","filing":"0001493152-26-037489","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633927/000149315226037489/ownership.xml","form_type":"4"}},{"id":800058,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":24126,"kind":"person","name":"Purcell Michael J.","position":1,"cik":"0001694934","reported_name":"Purcell Michael J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-04-27T21:33:08.000Z","date":"2026-04-21","kind":"purchase","planned":false,"acquired":true,"shares":1250000,"price":0.04,"value":50000.0,"ownership":{"direct":true},"balance_after":1250000,"source":{"system":"sec-edgar","filing":"0001493152-26-019202","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694934/000149315226019202/ownership.xml","form_type":"4"}},{"id":800037,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":20831,"kind":"person","name":"LoPriore Vincent S","position":1,"cik":"0001633927","reported_name":"LoPriore Vincent S","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-04-27T10:24:56.000Z","date":"2026-04-21","kind":"purchase","planned":false,"acquired":true,"shares":1250000,"price":0.04,"value":50000.0,"ownership":{"direct":false,"nature":"By Invictus Capital Advisors Pension Plan"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. LoPriore is the trustee and beneficiary of the Pension Plan and in such capacity has the right to vote and dispose of the securities held by such entity."}],"balance_after":6250000,"source":{"system":"sec-edgar","filing":"0001493152-26-019029","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1633927/000149315226019029/ownership.xml","form_type":"4"}},{"id":800036,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":20831,"kind":"person","name":"LoPriore Vincent S","position":1,"cik":"0001633927","reported_name":"LoPriore Vincent S","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-04-27T10:24:56.000Z","date":"2026-04-21","kind":"purchase","planned":false,"acquired":true,"shares":5000000,"price":0.04,"value":200000.0,"ownership":{"direct":false,"nature":"By Gravitas Capital LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. LoPriore is the Managing Member of Gravitas Capital LP and in such capacity has the right to vote and dispose of the securities held by such entity."}],"balance_after":5000000,"source":{"system":"sec-edgar","filing":"0001493152-26-019029","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633927/000149315226019029/ownership.xml","form_type":"4"}},{"id":799950,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":20757,"kind":"person","name":"Appajosyula Sireesh","position":1,"cik":"0001901565","reported_name":"Appajosyula Sireesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-04-27T10:24:50.000Z","date":"2026-04-21","kind":"purchase","planned":false,"acquired":true,"shares":1250000,"price":0.04,"value":50000.0,"ownership":{"direct":true},"balance_after":1250000,"source":{"system":"sec-edgar","filing":"0001493152-26-019028","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000149315226019028/ownership.xml","form_type":"4"}},{"id":799961,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":20773,"kind":"person","name":"Stetz Gary S.","position":1,"cik":"0001532793","reported_name":"Stetz Gary S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-04-27T10:24:44.000Z","date":"2026-04-21","kind":"purchase","planned":false,"acquired":true,"shares":1250000,"price":0.04,"value":50000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Through Stetz Belgiovine CPA 401K F/B/O Gary S. Stetz"}],"balance_after":1250000,"source":{"system":"sec-edgar","filing":"0001493152-26-019027","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1532793/000149315226019027/ownership.xml","form_type":"4"}},{"id":1589204,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":24126,"kind":"person","name":"Purcell Michael J.","position":1,"cik":"0001694934","reported_name":"Purcell Michael J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-03-07T21:15:14.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (RSU's) which represent a contingent right to receive one share of Common Stock for each RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon the earlier of (i) one year from date of grant or (ii) a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Reporting Person was granted restricted stock units (RSU's) which represent a contingent right to receive one share of Common Stock for each RSU."}],"balance_after":50000,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-24-009215","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694934/000149315224009215/ownership.xml","form_type":"4"}},{"id":1628124,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":94043,"kind":"person","name":"Block Timothy M.","position":1,"cik":"0001593465","reported_name":"Block Timothy M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-02-22T01:01:50.000Z","date":"2024-02-19","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":99562,"derivative":{"exercise_price":2.56,"exercise_date":"2024-02-19","expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001493152-24-007465","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000149315224007465/ownership.xml","form_type":"4"}},{"id":1628554,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-02-22T01:01:44.000Z","date":"2024-02-19","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":102120,"derivative":{"exercise_price":2.56,"exercise_date":"2024-02-19","expiration_date":"2026-02-19","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001493152-24-007462","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000149315224007462/ownership.xml","form_type":"4"}},{"id":1628443,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman"}}],"security":"Stock Options","published_at":"2024-02-22T01:01:32.000Z","date":"2024-02-19","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":99563,"derivative":{"exercise_price":2.56,"exercise_date":"2024-02-19","expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001493152-24-007463","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000149315224007463/ownership.xml","form_type":"4"}},{"id":1629787,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":94073,"kind":"person","name":"Lbiati Kaouthar","position":1,"cik":"0001938708","reported_name":"Lbiati Kaouthar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-02-21T20:01:38.000Z","date":"2024-02-19","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":88000,"derivative":{"exercise_price":2.56,"exercise_date":"2024-02-19","expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001493152-24-007464","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1938708/000149315224007464/ownership.xml","form_type":"4"}},{"id":1728708,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":107931,"kind":"person","name":"Wijngaard Peter","position":1,"cik":"0001778501","reported_name":"Wijngaard Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-28T06:55:05.000Z","date":"2023-11-27","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":3.05,"value":7625.0,"ownership":{"direct":true},"balance_after":9501,"source":{"system":"sec-edgar","filing":"0001104659-23-121427","document":"tm2331632-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1778501/000110465923121427/tm2331632-1_4seq1.xml","form_type":"4"}},{"id":1728707,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":107931,"kind":"person","name":"Wijngaard Peter","position":1,"cik":"0001778501","reported_name":"Wijngaard Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-28T06:55:05.000Z","date":"2023-11-24","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":3.09,"value":7725.0,"ownership":{"direct":true},"balance_after":7001,"source":{"system":"sec-edgar","filing":"0001104659-23-121427","document":"tm2331632-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778501/000110465923121427/tm2331632-1_4seq1.xml","form_type":"4"}},{"id":1776284,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":107931,"kind":"person","name":"Wijngaard Peter","position":1,"cik":"0001778501","reported_name":"Wijngaard Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-20T11:27:22.000Z","date":"2023-09-19","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":5.64,"value":5640.0,"ownership":{"direct":true},"balance_after":4501,"source":{"system":"sec-edgar","filing":"0001104659-23-102209","document":"tm2326377-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1778501/000110465923102209/tm2326377-2_4seq1.xml","form_type":"4"}},{"id":1776283,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":107931,"kind":"person","name":"Wijngaard Peter","position":1,"cik":"0001778501","reported_name":"Wijngaard Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-20T11:27:22.000Z","date":"2023-09-15","kind":"purchase","planned":false,"acquired":true,"shares":861,"price":5.37,"value":4623.57,"ownership":{"direct":true},"balance_after":3501,"source":{"system":"sec-edgar","filing":"0001104659-23-102209","document":"tm2326377-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1778501/000110465923102209/tm2326377-2_4seq1.xml","form_type":"4"}},{"id":1776282,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":107931,"kind":"person","name":"Wijngaard Peter","position":1,"cik":"0001778501","reported_name":"Wijngaard Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-20T11:27:22.000Z","date":"2023-09-15","kind":"purchase","planned":false,"acquired":true,"shares":139,"price":5.45,"value":757.55,"ownership":{"direct":true},"balance_after":2640,"source":{"system":"sec-edgar","filing":"0001104659-23-102209","document":"tm2326377-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1778501/000110465923102209/tm2326377-2_4seq1.xml","form_type":"4"}},{"id":1776281,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":107931,"kind":"person","name":"Wijngaard Peter","position":1,"cik":"0001778501","reported_name":"Wijngaard Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-20T11:27:22.000Z","date":"2023-09-15","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":5.82,"value":5820.0,"ownership":{"direct":true},"balance_after":2501,"source":{"system":"sec-edgar","filing":"0001104659-23-102209","document":"tm2326377-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778501/000110465923102209/tm2326377-2_4seq1.xml","form_type":"4"}},{"id":1777014,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":109482,"kind":"person","name":"Foster Robert T","position":1,"cik":"0001677370","reported_name":"Foster Robert T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common Stock","published_at":"2023-09-19T13:01:30.000Z","date":"2023-09-18","kind":"purchase","planned":false,"acquired":true,"shares":1600,"price":5.6,"value":8960.0,"ownership":{"direct":true},"balance_after":50470,"source":{"system":"sec-edgar","filing":"0001104659-23-101784","document":"tm2326377-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000110465923101784/tm2326377-1_4seq1.xml","form_type":"4"}},{"id":1778653,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":109482,"kind":"person","name":"Foster Robert T","position":1,"cik":"0001677370","reported_name":"Foster Robert T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,CSO and Director"}}],"security":"Common Stock","published_at":"2023-09-18T12:00:24.000Z","date":"2023-09-15","kind":"purchase","planned":false,"acquired":true,"shares":1600,"price":5.4,"value":8640.0,"ownership":{"direct":true},"balance_after":48870,"source":{"system":"sec-edgar","filing":"0001104659-23-101391","document":"tm2326273-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000110465923101391/tm2326273-1_4seq1.xml","form_type":"4"}},{"id":2702805,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-05-20T20:36:51.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan."}],"balance_after":342785,"derivative":{"exercise_price":1.7,"exercise_date":"2022-05-18","expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001104659-21-069940","document":"tm2117144d6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465921069940/tm2117144d6_4seq1.xml","form_type":"4"}},{"id":2702500,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":109482,"kind":"person","name":"Foster Robert T","position":1,"cik":"0001677370","reported_name":"Foster Robert T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CSO and Director"}}],"security":"Stock Options","published_at":"2021-05-20T20:36:01.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":1900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"633,333 of the stock options vest on 5/18/2022 and the remainder vests monthly in equal amounts over 24 months."}],"balance_after":2501879,"derivative":{"exercise_price":1.7,"expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":1900000},"source":{"system":"sec-edgar","filing":"0001104659-21-069939","document":"tm2117144-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000110465921069939/tm2117144-5_4seq1.xml","form_type":"4"}},{"id":2702674,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-05-20T20:34:50.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan."}],"balance_after":291332,"derivative":{"exercise_price":1.7,"exercise_date":"2022-05-18","expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-21-069936","document":"tm2117144d3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465921069936/tm2117144d3_4seq1.xml","form_type":"4"}},{"id":2702499,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":94043,"kind":"person","name":"Block Timothy M.","position":1,"cik":"0001593465","reported_name":"Block Timothy M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-05-20T20:34:18.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan."}],"balance_after":291276,"derivative":{"exercise_price":1.7,"exercise_date":"2022-05-18","expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-21-069935","document":"tm2117144-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000110465921069935/tm2117144-2_4seq1.xml","form_type":"4"}},{"id":2702655,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-05-20T19:12:44.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan."}],"balance_after":291110,"derivative":{"exercise_price":1.7,"exercise_date":"2022-05-18","expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-21-070074","document":"tm2117144-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363763/000110465921070074/tm2117144-7_4seq1.xml","form_type":"4"}},{"id":2703424,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":107931,"kind":"person","name":"Wijngaard Peter","position":1,"cik":"0001778501","reported_name":"Wijngaard Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-05-20T16:37:22.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan."}],"balance_after":260000,"derivative":{"exercise_price":1.7,"exercise_date":"2022-05-18","expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-21-069942","document":"tm2117144-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778501/000110465921069942/tm2117144-8_4seq1.xml","form_type":"4"}},{"id":2702600,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139177,"kind":"person","name":"Cavan John T","position":1,"cik":"0001503738","reported_name":"Cavan John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2021-05-20T16:35:39.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":1200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"400,000 of the stock options vest on 5/18/2022 and the remainder vests monthly in equal amounts over 24 months."}],"balance_after":1581060,"derivative":{"exercise_price":1.7,"expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":1200000},"source":{"system":"sec-edgar","filing":"0001104659-21-069938","document":"tm2117144-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503738/000110465921069938/tm2117144-4_4seq1.xml","form_type":"4"}},{"id":2702769,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-05-20T16:33:46.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan."}],"balance_after":291050,"derivative":{"exercise_price":1.7,"exercise_date":"2022-05-18","expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-21-069934","document":"tm2117144-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000110465921069934/tm2117144-1_4seq1.xml","form_type":"4"}},{"id":2848845,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":109482,"kind":"person","name":"Foster Robert T","position":1,"cik":"0001677370","reported_name":"Foster Robert T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common Stock","published_at":"2021-02-18T21:05:53.000Z","date":"2021-02-18","kind":"purchase","acquired":true,"shares":20000,"price":2,"value":40000.0,"ownership":{"direct":true},"balance_after":45259,"source":{"system":"sec-edgar","filing":"0001104659-21-025199","document":"tm217063-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000110465921025199/tm217063-2_4seq1.xml","form_type":"4"}},{"id":2850586,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":107931,"kind":"person","name":"Wijngaard Peter","position":1,"cik":"0001778501","reported_name":"Wijngaard Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-18T16:06:55.000Z","date":"2021-02-16","kind":"purchase","acquired":true,"shares":10000,"price":2.2,"value":22000.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001104659-21-025200","document":"tm217063-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778501/000110465921025200/tm217063-3_4seq1.xml","form_type":"4"}},{"id":2849085,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139177,"kind":"person","name":"Cavan John T","position":1,"cik":"0001503738","reported_name":"Cavan John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-18T16:05:28.000Z","date":"2021-02-18","kind":"purchase","acquired":true,"shares":10000,"price":2,"value":20000.0,"ownership":{"direct":true},"balance_after":14800,"source":{"system":"sec-edgar","filing":"0001104659-21-025196","document":"tm217063-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503738/000110465921025196/tm217063-1_4seq1.xml","form_type":"4"}},{"id":2936336,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":107931,"kind":"person","name":"Wijngaard Peter","position":1,"cik":"0001778501","reported_name":"Wijngaard Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-21T09:17:57.000Z","date":"2020-12-18","kind":"purchase","acquired":true,"shares":20000,"price":1.91,"value":38200.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001104659-20-137755","document":"tm2038991d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778501/000110465920137755/tm2038991d1_4.xml","form_type":"4"}},{"id":2953024,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":109482,"kind":"person","name":"Foster Robert T","position":1,"cik":"0001677370","reported_name":"Foster Robert T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common Stock","published_at":"2020-12-08T18:56:11.000Z","date":"2020-12-08","kind":"purchase","acquired":true,"shares":25000,"price":1.5767,"value":39417.5,"ownership":{"direct":true},"balance_after":25259,"source":{"system":"sec-edgar","filing":"0001104659-20-133141","document":"tm2037967-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000110465920133141/tm2037967-1_4seq1.xml","form_type":"4"}},{"id":2960321,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-02T23:05:24.000Z","date":"2020-12-02","kind":"purchase","acquired":true,"shares":7000,"price":1.53,"value":10710.0,"ownership":{"direct":true},"balance_after":7008,"source":{"system":"sec-edgar","filing":"0001104659-20-131656","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465920131656/a4.xml","form_type":"4"}},{"id":2962568,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-02T00:53:08.000Z","date":"2020-12-01","kind":"purchase","acquired":true,"shares":12000,"price":1.66,"value":19920.0,"ownership":{"direct":true},"balance_after":12059,"source":{"system":"sec-edgar","filing":"0001104659-20-131213","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465920131213/a4.xml","form_type":"4"}},{"id":2963892,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139177,"kind":"person","name":"Cavan John T","position":1,"cik":"0001503738","reported_name":"Cavan John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-11-30T16:53:23.000Z","date":"2020-11-25","kind":"purchase","acquired":true,"shares":4500,"price":1.62,"value":7290.0,"ownership":{"direct":true},"balance_after":4800,"source":{"system":"sec-edgar","filing":"0001104659-20-130531","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503738/000110465920130531/a4.xml","form_type":"4"}},{"id":3049587,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":109482,"kind":"person","name":"Foster Robert T","position":1,"cik":"0001677370","reported_name":"Foster Robert T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,CSO and Director"}}],"security":"Stock Options","published_at":"2020-08-21T20:17:58.000Z","date":"2020-08-19","kind":"grant","acquired":true,"shares":212000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"70,667 of the stock options vest on 8/19/2021 and the remainder vests monthly in equal amounts over 24 months."}],"balance_after":601879,"derivative":{"exercise_price":3.72,"expiration_date":"2030-08-19","underlying":"Common Stock","underlying_shares":212000},"source":{"system":"sec-edgar","filing":"0001104659-20-097602","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000110465920097602/a4.xml","form_type":"4"}},{"id":3049586,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":94043,"kind":"person","name":"Block Timothy M.","position":1,"cik":"0001593465","reported_name":"Block Timothy M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-08-21T20:17:15.000Z","date":"2020-08-19","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":91276,"derivative":{"exercise_price":3.72,"exercise_date":"2021-08-19","expiration_date":"2030-08-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-20-097599","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000110465920097599/a4.xml","form_type":"4"}},{"id":3049712,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-08-21T20:16:28.000Z","date":"2020-08-19","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":91332,"derivative":{"exercise_price":3.72,"exercise_date":"2021-08-19","expiration_date":"2030-08-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-20-097596","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465920097596/a4.xml","form_type":"4"}},{"id":3049749,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-08-21T20:15:43.000Z","date":"2020-08-19","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":92785,"derivative":{"exercise_price":3.72,"exercise_date":"2021-08-19","expiration_date":"2030-08-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-20-097593","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465920097593/a4.xml","form_type":"4"}},{"id":3049696,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-08-21T16:17:43.000Z","date":"2020-08-19","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":91110,"derivative":{"exercise_price":3.72,"exercise_date":"2021-08-19","expiration_date":"2030-08-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-20-097600","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363763/000110465920097600/a4.xml","form_type":"4"}},{"id":3049734,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-08-21T16:16:58.000Z","date":"2020-08-19","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":91050,"derivative":{"exercise_price":3.72,"exercise_date":"2021-08-19","expiration_date":"2030-08-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-20-097598","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000110465920097598/a4.xml","form_type":"4"}},{"id":3050044,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":107931,"kind":"person","name":"Wijngaard Peter","position":1,"cik":"0001778501","reported_name":"Wijngaard Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-08-21T16:15:29.000Z","date":"2020-08-19","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":60000,"derivative":{"exercise_price":3.72,"exercise_date":"2021-08-19","expiration_date":"2030-08-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-20-097592","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778501/000110465920097592/a4.xml","form_type":"4"}},{"id":3049653,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139177,"kind":"person","name":"Cavan John T","position":1,"cik":"0001503738","reported_name":"Cavan John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2020-08-21T16:15:29.000Z","date":"2020-08-19","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"53,333 of the stock options vest on 8/19/2021 and the remainder vests monthly in equal amounts over 24 months."}],"balance_after":381060,"derivative":{"exercise_price":3.72,"expiration_date":"2030-08-19","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001104659-20-097591","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503738/000110465920097591/a4.xml","form_type":"4"}},{"id":3099875,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":107931,"kind":"person","name":"Wijngaard Peter","position":1,"cik":"0001778501","reported_name":"Wijngaard Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-06-25T19:18:02.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"10,000 of the options vest on each of 6/25/2021, 2022 and 2023."}],"balance_after":30000,"derivative":{"exercise_price":2.73,"expiration_date":"2030-06-25","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-20-076967","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778501/000110465920076967/a4.xml","form_type":"4"}},{"id":3180230,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":94043,"kind":"person","name":"Block Timothy M.","position":1,"cik":"0001593465","reported_name":"Block Timothy M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-04-07T20:14:56.000Z","date":"2020-04-03","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":61220,"derivative":{"exercise_price":1.63,"exercise_date":"2021-04-03","expiration_date":"2030-04-03","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-20-044174","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000110465920044174/a4.xml","form_type":"4"}},{"id":3180438,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-04-07T20:14:11.000Z","date":"2020-04-03","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":61275,"derivative":{"exercise_price":1.63,"exercise_date":"2021-04-03","expiration_date":"2030-04-03","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-20-044171","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465920044171/a4.xml","form_type":"4"}},{"id":3180364,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":109482,"kind":"person","name":"Foster Robert T","position":1,"cik":"0001677370","reported_name":"Foster Robert T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CSO"}}],"security":"Stock Options","published_at":"2020-04-07T20:13:56.000Z","date":"2020-04-03","kind":"grant","acquired":true,"shares":380000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"126,667 of the stock options vest on 4/3/2021 and the remainder vests monthly in equal amounts over 24 months."}],"balance_after":389879,"derivative":{"exercise_price":1.63,"expiration_date":"2030-04-03","underlying":"Common Stock","underlying_shares":380000},"source":{"system":"sec-edgar","filing":"0001104659-20-044170","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000110465920044170/a4.xml","form_type":"4"}},{"id":3180473,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-04-07T20:13:26.000Z","date":"2020-04-03","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":62729,"derivative":{"exercise_price":1.63,"exercise_date":"2021-04-03","expiration_date":"2030-04-03","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-20-044169","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465920044169/a4.xml","form_type":"4"}},{"id":3180466,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-04-07T16:15:11.000Z","date":"2020-04-03","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":61051,"derivative":{"exercise_price":1.63,"exercise_date":"2021-04-03","expiration_date":"2030-04-03","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-20-044175","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000110465920044175/a4.xml","form_type":"4"}},{"id":3180401,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-04-07T16:14:41.000Z","date":"2020-04-03","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":61109,"derivative":{"exercise_price":1.63,"exercise_date":"2021-04-03","expiration_date":"2030-04-03","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-20-044173","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363763/000110465920044173/a4.xml","form_type":"4"}},{"id":3180363,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139177,"kind":"person","name":"Cavan John T","position":1,"cik":"0001503738","reported_name":"Cavan John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2020-04-07T16:13:11.000Z","date":"2020-04-03","kind":"grant","acquired":true,"shares":215000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"71,667 of the stock options vest on 4/3/2021 and the remainder vests monthly in equal amounts over 24 months."}],"balance_after":221059,"derivative":{"exercise_price":1.63,"expiration_date":"2030-04-03","underlying":"Common Stock","underlying_shares":215000},"source":{"system":"sec-edgar","filing":"0001104659-20-044168","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503738/000110465920044168/a4.xml","form_type":"4"}},{"id":3455921,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-07-25T20:16:21.000Z","date":"2019-07-24","kind":"grant","acquired":true,"shares":970,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2729,"derivative":{"exercise_price":3.24,"exercise_date":"2019-07-24","expiration_date":"2029-07-24","underlying":"Common Stock","underlying_shares":970},"source":{"system":"sec-edgar","filing":"0001104659-19-041850","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465919041850/a4.xml","form_type":"4"}},{"id":3455845,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-07-25T20:16:06.000Z","date":"2019-07-24","kind":"grant","acquired":true,"shares":970,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1275,"derivative":{"exercise_price":3.24,"exercise_date":"2019-07-24","expiration_date":"2029-07-24","underlying":"Common Stock","underlying_shares":970},"source":{"system":"sec-edgar","filing":"0001104659-19-041849","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465919041849/a4.xml","form_type":"4"}},{"id":3455810,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":94043,"kind":"person","name":"Block Timothy M.","position":1,"cik":"0001593465","reported_name":"Block Timothy M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-07-25T20:15:53.000Z","date":"2019-07-24","kind":"grant","acquired":true,"shares":970,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1220,"derivative":{"exercise_price":3.24,"exercise_date":"2019-07-24","expiration_date":"2029-07-24","underlying":"Common Stock","underlying_shares":970},"source":{"system":"sec-edgar","filing":"0001104659-19-041847","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000110465919041847/a4.xml","form_type":"4"}},{"id":3455809,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":109482,"kind":"person","name":"Foster Robert T","position":1,"cik":"0001677370","reported_name":"Foster Robert T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CSO"}}],"security":"Stock Options","published_at":"2019-07-25T20:15:22.000Z","date":"2019-07-24","kind":"grant","acquired":true,"shares":9700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest in three installments as follows: 3,233 vest on each of July 24, 2020 and 2021 and 3,234 vest on July 24, 2022."}],"balance_after":9879,"derivative":{"exercise_price":3.24,"expiration_date":"2029-07-24","underlying":"Common Stock","underlying_shares":9700},"source":{"system":"sec-edgar","filing":"0001104659-19-041844","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000110465919041844/a4.xml","form_type":"4"}},{"id":3455822,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139177,"kind":"person","name":"Cavan John T","position":1,"cik":"0001503738","reported_name":"Cavan John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2019-07-25T16:16:52.000Z","date":"2019-07-24","kind":"grant","acquired":true,"shares":5820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest in three installments as follows: 1,940 options shall vest on each of July 24, 2020, 2021 and 2022."}],"balance_after":6059,"derivative":{"exercise_price":3.24,"expiration_date":"2029-07-24","underlying":"Common Stock","underlying_shares":5820},"source":{"system":"sec-edgar","filing":"0001104659-19-041851","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503738/000110465919041851/a4.xml","form_type":"4"}},{"id":3455920,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-07-25T16:15:38.000Z","date":"2019-07-24","kind":"grant","acquired":true,"shares":970,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1051,"derivative":{"exercise_price":3.24,"exercise_date":"2019-07-24","expiration_date":"2029-07-24","underlying":"Common Stock","underlying_shares":970},"source":{"system":"sec-edgar","filing":"0001104659-19-041845","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000110465919041845/a4.xml","form_type":"4"}},{"id":3455833,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-07-25T16:15:22.000Z","date":"2019-07-24","kind":"grant","acquired":true,"shares":970,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1109,"derivative":{"exercise_price":3.24,"exercise_date":"2019-07-24","expiration_date":"2029-07-24","underlying":"Common Stock","underlying_shares":970},"source":{"system":"sec-edgar","filing":"0001104659-19-041843","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363763/000110465919041843/a4.xml","form_type":"4"}},{"id":3874537,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2018-07-03T18:17:43.000Z","date":"2018-07-03","kind":"purchase","acquired":true,"shares":8625,"price":1000,"value":8625000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series C Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series C Convertible Preferred Stock and 575 Warrants"}],"balance_after":8625,"derivative":{"exercise_price":1.55,"exercise_date":"2018-07-03","expiration_date":"2023-07-03","underlying":"Common Stock","underlying_shares":8625},"source":{"system":"sec-edgar","filing":"0001104659-18-043798","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465918043798/a4.xml","form_type":"4"}},{"id":3874536,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2018-07-03T18:17:43.000Z","date":"2018-07-03","kind":"purchase","acquired":true,"shares":15,"price":1000,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series C Convertible Preferred Stock is convertible into the number of shares of Common Stock equal to the stated value of $1,000 divided by $1.55."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series C Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series C Convertible Preferred Stock and 575 Warrants"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of Series C Convertible Preferred Stock do not expire."}],"balance_after":15,"derivative":{"exercise_price":1.55,"exercise_date":"2018-07-03","underlying":"Common Stock","underlying_shares":9678},"source":{"system":"sec-edgar","filing":"0001104659-18-043798","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465918043798/a4.xml","form_type":"4"}},{"id":3874334,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2018-07-03T18:16:44.000Z","date":"2018-07-03","kind":"purchase","acquired":true,"shares":1725,"price":1000,"value":1725000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series C Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series C Convertible Preferred Stock and 575 Warrants"}],"balance_after":1725,"derivative":{"exercise_price":1.55,"exercise_date":"2018-07-03","expiration_date":"2023-07-03","underlying":"Common Stock","underlying_shares":1725},"source":{"system":"sec-edgar","filing":"0001104659-18-043792","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465918043792/a4.xml","form_type":"4"}},{"id":3874333,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2018-07-03T18:16:44.000Z","date":"2018-07-03","kind":"purchase","acquired":true,"shares":3,"price":1000,"value":3000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series C Convertible Preferred Stock is convertible into the number of shares of Common Stock equal to the stated value of $1,000 divided by $1.55."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series C Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series C Convertible Preferred Stock and 575 Warrants"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of Series C Convertible Preferred Stock do not expire."}],"balance_after":3,"derivative":{"exercise_price":1.55,"exercise_date":"2018-07-03","underlying":"Common Stock","underlying_shares":1936},"source":{"system":"sec-edgar","filing":"0001104659-18-043792","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000110465918043792/a4.xml","form_type":"4"}},{"id":3874114,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139177,"kind":"person","name":"Cavan John T","position":1,"cik":"0001503738","reported_name":"Cavan John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Warrants","published_at":"2018-07-03T14:17:28.000Z","date":"2018-07-03","kind":"purchase","acquired":true,"shares":8625,"price":1000,"value":8625000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series C Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series C Convertible Preferred Stock and 575 Warrants"}],"balance_after":8625,"derivative":{"exercise_price":1.55,"exercise_date":"2018-07-03","expiration_date":"2023-07-03","underlying":"Common Stock","underlying_shares":8625},"source":{"system":"sec-edgar","filing":"0001104659-18-043797","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503738/000110465918043797/a4.xml","form_type":"4"}},{"id":3874113,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139177,"kind":"person","name":"Cavan John T","position":1,"cik":"0001503738","reported_name":"Cavan John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Series C Convertible Preferred Stock","published_at":"2018-07-03T14:17:28.000Z","date":"2018-07-03","kind":"purchase","acquired":true,"shares":15,"price":1000,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series C Convertible Preferred Stock is convertible into the number of shares of Common Stock equal to the stated value of $1,000 divided by $1.55."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series C Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series C Convertible Preferred Stock and 575 Warrants"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of Series C Convertible Preferred Stock do not expire."}],"balance_after":15,"derivative":{"exercise_price":1.55,"exercise_date":"2018-07-03","underlying":"Common Stock","underlying_shares":9678},"source":{"system":"sec-edgar","filing":"0001104659-18-043797","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503738/000110465918043797/a4.xml","form_type":"4"}},{"id":3874239,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2018-07-03T14:16:58.000Z","date":"2018-07-03","kind":"purchase","acquired":true,"shares":8625,"price":1000,"value":8625000.0,"ownership":{"direct":false,"nature":"Linda Lippa Family Trust of 2007"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series C Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series C Convertible Preferred Stock and 575 Warrants"}],"balance_after":8625,"derivative":{"exercise_price":1.55,"exercise_date":"2018-07-03","expiration_date":"2023-07-03","underlying":"Common Stock","underlying_shares":8625},"source":{"system":"sec-edgar","filing":"0001104659-18-043794","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1363763/000110465918043794/a4.xml","form_type":"4"}},{"id":3874238,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139178,"kind":"person","name":"Lippa Arnold","position":1,"cik":"0001363763","reported_name":"Lippa Arnold","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2018-07-03T14:16:58.000Z","date":"2018-07-03","kind":"purchase","acquired":true,"shares":15,"price":1000,"value":15000.0,"ownership":{"direct":false,"nature":"Linda Lippa Family Trust of 2007"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series C Convertible Preferred Stock is convertible into the number of shares of Common Stock equal to the stated value of $1,000 divided by $1.55."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series C Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series C Convertible Preferred Stock and 575 Warrants"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of Series C Convertible Preferred Stock do not expire."}],"balance_after":15,"derivative":{"exercise_price":1.55,"exercise_date":"2018-07-03","underlying":"Common Stock","underlying_shares":9678},"source":{"system":"sec-edgar","filing":"0001104659-18-043794","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363763/000110465918043794/a4.xml","form_type":"4"}},{"id":4105021,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":109482,"kind":"person","name":"Foster Robert T","position":1,"cik":"0001677370","reported_name":"Foster Robert T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-01-05T18:08:53.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":100654,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan.  All of the shares vested upon grant.  Such shares were issued in lieu of a cash bonus to the reporting person."}],"balance_after":144736,"source":{"system":"sec-edgar","filing":"0001104659-18-000922","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000110465918000922/a4.xml","form_type":"4"}},{"id":4105114,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139177,"kind":"person","name":"Cavan John T","position":1,"cik":"0001503738","reported_name":"Cavan John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2018-01-05T13:09:52.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":101221,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan.  All of the shares vested upon grant.  Such shares were issued in lieu of a cash bonus to the reporting person."}],"balance_after":167947,"source":{"system":"sec-edgar","filing":"0001104659-18-000925","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503738/000110465918000925/a4.xml","form_type":"4"}},{"id":4105064,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":41703,"kind":"person","name":"SAPIRSTEIN JAMES","position":1,"cik":"0001559509","reported_name":"SAPIRSTEIN JAMES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-01-05T13:09:23.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":322092,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan.  All of the shares vested upon grant.  Such shares were issued in lieu of a cash bonus to the reporting person."}],"balance_after":492819,"source":{"system":"sec-edgar","filing":"0001104659-18-000924","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559509/000110465918000924/a4.xml","form_type":"4"}},{"id":4253116,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139177,"kind":"person","name":"Cavan John T","position":1,"cik":"0001503738","reported_name":"Cavan John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2017-07-21T16:01:01.000Z","date":"2017-07-20","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest in three installments as follows: 5,000 vest on each of July 20, 2018, 2019 and 2020."}],"balance_after":133688,"derivative":{"exercise_price":0.58,"expiration_date":"2027-07-20","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-17-046277","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503738/000110465917046277/a4.xml","form_type":"4"}},{"id":4260673,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":109482,"kind":"person","name":"Foster Robert T","position":1,"cik":"0001677370","reported_name":"Foster Robert T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-07-07T21:00:43.000Z","date":"2017-07-06","kind":"grant","acquired":true,"shares":44082,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan.  All of the shares vested upon grant.  Such shares were issued in lieu of a cash bonus to the reporting person."}],"balance_after":44082,"source":{"system":"sec-edgar","filing":"0001104659-17-044097","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000110465917044097/a4.xml","form_type":"4"}},{"id":4260719,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139177,"kind":"person","name":"Cavan John T","position":1,"cik":"0001503738","reported_name":"Cavan John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2017-07-07T17:01:27.000Z","date":"2017-07-06","kind":"grant","acquired":true,"shares":46726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan.  All of the shares vested upon grant.  Such shares were issued in lieu of a cash bonus to the reporting person."}],"balance_after":66726,"source":{"system":"sec-edgar","filing":"0001104659-17-044101","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503738/000110465917044101/a4.xml","form_type":"4"}},{"id":4260681,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":41703,"kind":"person","name":"SAPIRSTEIN JAMES","position":1,"cik":"0001559509","reported_name":"SAPIRSTEIN JAMES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-07-07T17:01:12.000Z","date":"2017-07-06","kind":"grant","acquired":true,"shares":141061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan.  All of the shares vested upon grant.  Such shares were issued in lieu of a cash bonus to the reporting person."}],"balance_after":170727,"source":{"system":"sec-edgar","filing":"0001104659-17-044100","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559509/000110465917044100/a4.xml","form_type":"4"}},{"id":4260923,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":174534,"kind":"person","name":"Sullivan-Bolyai John Z","position":1,"cik":"0001668462","reported_name":"Sullivan-Bolyai John Z","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-07-07T17:00:57.000Z","date":"2017-07-06","kind":"grant","acquired":true,"shares":58681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan.  All of the shares vested upon grant.  Such shares were issued in lieu of a cash bonus to the reporting person."}],"balance_after":58681,"source":{"system":"sec-edgar","filing":"0001104659-17-044099","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668462/000110465917044099/a4.xml","form_type":"4"}},{"id":4274254,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139177,"kind":"person","name":"Cavan John T","position":1,"cik":"0001503738","reported_name":"Cavan John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2017-06-22T09:00:25.000Z","date":"2017-06-20","kind":"purchase","acquired":true,"shares":20000,"price":0.65,"value":13000.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001104659-17-040822","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503738/000110465917040822/a4.xml","form_type":"4"}},{"id":4354324,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-04-11T20:02:43.000Z","date":"2017-04-10","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest in three installments as follows: 11,667 of the options vest on each of April 10, 2018 and 2019 and 11,666 vest on April 10, 2020."}],"balance_after":80000,"derivative":{"exercise_price":1.6,"expiration_date":"2027-04-10","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-17-022871","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202286/000110465917022871/a4.xml","form_type":"4"}},{"id":4396662,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":41703,"kind":"person","name":"SAPIRSTEIN JAMES","position":1,"cik":"0001559509","reported_name":"SAPIRSTEIN JAMES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2017-03-07T16:00:38.000Z","date":"2017-03-06","kind":"grant","acquired":true,"shares":313898,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vest in three installments as follows: 104,632 of the options vest on each of March 6, 2018 and 2019 and 104,634 vest on March 6, 2020."}],"balance_after":2761129,"derivative":{"exercise_price":1.48,"expiration_date":"2027-03-06","underlying":"Common Stock","underlying_shares":313898},"source":{"system":"sec-edgar","filing":"0001104659-17-014835","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559509/000110465917014835/a4.xml","form_type":"4"}},{"id":4396661,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":41703,"kind":"person","name":"SAPIRSTEIN JAMES","position":1,"cik":"0001559509","reported_name":"SAPIRSTEIN JAMES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2017-03-07T16:00:38.000Z","date":"2017-03-03","kind":"grant","acquired":true,"shares":313898,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest in three installments as follows: 104,632 of the options vest on each of March 3, 2018 and 2019 and 104,634 vest on March 3, 2020."}],"balance_after":2447231,"derivative":{"exercise_price":1.43,"expiration_date":"2027-03-03","underlying":"Common Stock","underlying_shares":313898},"source":{"system":"sec-edgar","filing":"0001104659-17-014835","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559509/000110465917014835/a4.xml","form_type":"4"}}],"next_cursor":"2017-03-07T16:00:38.000000Z,4396661"}